QT Sense

Nervonik, founded in 2020 in Los Angeles, California, USA, develops implantable peripheral nerve stimulation devices that deliver personalized chronic pain treatment through electrical signals and real-time sensing.

METiS Technologies, founded in 2015 in Beijing, China, develops AI-powered nanotechnology instruments that help pharmaceutical companies observe and manipulate molecular interactions within living cells.

Sensible Biotechnologies, founded in 2021 and headquartered in Oxford with process development and cGMP manufacturing in Slovakia, builds VECTOR, a platform that uses engineered living cells instead of in-vitro transcription to design, optimize and manufacture naturally modified mRNA, integrating computational and AI-enabled sequence optimization.

Coherence Neuro is a San Francisco-based medical neurotechnology company founded in 2022 by Cambridge Bioelectronics Laboratory alumni Ben Woodington (CEO) and Elise Jenkins. Its SOMA system is a coin-sized wireless implant paired with a wearable and app that continuously records tumor-microenvironment electrical activity, uses AI to decode each tumor's electrical signature and delivers targeted stimulation; it has begun first-in-human studies during brain tumor resection.